Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer

• Xin Liu,

  Affiliation Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China

  ⨯
• Shouyu Wang,

  Affiliation Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China

  ⨯
• Xiaowei Xia,

  Affiliation Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China

  ⨯
• Yansu Chen,

  Affiliation Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China

  ⨯
• Yan Zhou,

  Affiliation Department of Oncology, Yixing Hospital, Yixing, Jiangsu Province, People’s Republic of China

  ⨯
• Xuming Wu,

  Affiliations Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China, Department of Pathology, Nantong Cancer Hospital, Nantong, Jiangsu Province, People’s Republic of China

  ⨯
• Jianbing Zhang,

  Affiliations Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China, Department of Pathology, Nantong Cancer Hospital, Nantong, Jiangsu Province, People’s Republic of China

  ⨯
• Song He,

  Affiliation Department of Pathology, Nantong Cancer Hospital, Nantong, Jiangsu Province, People’s Republic of China

  ⨯
• Yongfei Tan,

  Affiliation Department of Oncology, Yixing Hospital, Yixing, Jiangsu Province, People’s Republic of China

  ⨯
• Fulin Qiang,

  Affiliation Department of Pathology, Nantong Cancer Hospital, Nantong, Jiangsu Province, People’s Republic of China

  ⨯
• Oluf Dimitri Røe,

  Affiliation Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Gang Li,

  Affiliation Department of Dermatology and Skin Science, Jack Bell Research Centre, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Jianwei Zhou

  * E-mail: jwzhou@njmu.edu.cn

  Affiliation Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China

  ⨯